The short answer: An internal bra is a term used for additional support techniques during breast surgery, often involving an implanted scaffold or mesh. Ask what exact technique and material are proposed: the name alone does not establish the benefit, risk, or regulatory status. ASPS internal bra explainer, FDA mesh communication
The full story: “Internal bra” sounds like a neat answer to keeping a result in place. Before treating it as an upgrade, find out what the surgeon actually plans to do and what evidence supports it for your operation.
What does an internal bra actually mean?
ASPS describes an internal bra as an adjunct—a technique added to an operation—rather than a standalone procedure. In its explainer, surgeons discuss scaffolding placed to support breast tissue during operations such as a lift, augmentation, or reduction. ASPS internal bra explainer
Scaffold means a material used as a framework for support. Absorbable means a material is designed to break down in the body over time. Those descriptions still need a specific product and plan behind them. ASPS internal bra explainer
Ask whether your surgeon means sutures and your own tissue, an implanted material, or a combination. Do not assume every practice uses the phrase in the same way.
Is an internal bra the same as a breast lift?
Do not treat the terms as interchangeable. A lift reshapes tissue and removes excess skin; an internal support technique may be added to another breast operation. Ask what the main operation does and what the support technique is meant to add. ASPS lift overview, ASPS internal bra explainer
If you are trying to avoid a lift, ask that question directly. A discussion about support should not leave the procedure itself unclear.
Are breast meshes FDA approved?
The FDA's November 2023 communication states that surgical meshes have not been cleared or approved specifically for breast surgery, including augmentation or reconstruction. It distinguishes general soft-tissue clearance from a determination of safety and effectiveness for breast use. FDA mesh communication
Off-label use means using a device outside its cleared or approved indication. Ask the surgeon to explain the proposed product's current labeling and whether the planned use is off-label. FDA intended-use guidance
For GalaFLEX, the FDA letter specifically identifies scaffold products cleared for soft-tissue repair and reinforcement. That clearance should not be described as breast-specific approval. FDA mesh communication
What does the evidence say about longer lasting results?
Evidence should be read by material, procedure, and follow-up period. A 2025 prospective study followed 60 lift patients for 12 months and reported better maintenance of a measured breast-position outcome with GalaFLEX support. That finding does not establish a lifetime benefit or a result for every operation. Buccheri and colleagues, 2025
A 2021 systematic review identified 10 relevant studies and found low-quality, inconsistent evidence; it did not establish that mesh reliably prevents recurrent sagging or downward movement of breast tissue. Newer studies should be assessed alongside those limitations. Systematic review, 2021
Ask which study most closely matches your proposed procedure and how long it followed patients. A photograph taken shortly after surgery cannot establish a long-term advantage.
What risks should you ask about?
Read the proposed material's own risk information. BD's GalaFLEX patient brochure lists possible complications including infection, pain, fluid collection, material migration, and wound separation. Fluid collection, also called a seroma, and wound separation, also called dehiscence, deserve plain-English explanations in the consultation. BD patient brochure
Those are possible complications, not a claim that everyone experiences them. Ask how a problem would be evaluated, whether further treatment or removal might be needed, and what a future revision would involve.
What should you ask before agreeing?
Bring these six questions:
- What exact technique and product do you propose?
- What specific problem are you trying to address in my case?
- What evidence supports adding it to this operation?
- What are my options without it?
- What extra risks, costs, and follow-up are involved?
- How would it affect treatment if I needed another operation?
Ask to compare the proposed plans in writing. You do not have to decide on an added technique because it has an appealing name.
Frequently asked questions
Does an internal bra guarantee that breasts will never sag again?
No guarantee follows from the available studies. The 2025 study above followed patients for 12 months, and earlier evidence had important limitations. Ask for realistic expectations for the exact procedure. 2025 study, 2021 review
Is GalaFLEX a breast implant brand?
GalaFLEX is a scaffold product used for tissue reinforcement, not an implant that adds breast volume. Its proposed role and labeling should be discussed separately from your breast implant choice. FDA mesh communication
Should I have mesh removed if I already have it?
Do not make that decision from an online explainer. The FDA's communication does not recommend removal or reoperation for patients without symptoms. Bring concerns or symptoms to your treating clinician for an individual assessment. FDA mesh communication
This is general educational information, not an individual surgical assessment or product recommendation. A qualified clinician should explain your options, risks, and care.